| 3.35 Data as of May 20 | +0.11 / +3.40%Today’s Change | 1.89 Today|||52-Week Range 3.63 | +68.34% Year-to-Date |
The 4 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 5.25, with a high estimate of 8.00 and a low estimate of 3.75. The median estimate represents a +56.72% increase from the last price of 3.35.

The current consensus among 4 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




